England’s Health Service Will Stop Giving Puberty Blockers to Children at Gender Clinics

The National Health Service said Friday that ‘outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents.’

AP/Lefteris Pitarakis, file
The rainbow flag flies near Nelson's Column at Trafalgar Square, London, March 28, 2014. AP/Lefteris Pitarakis, file

LONDON — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.

Have an account? Log In

To continue reading, please select:

Limited Access

Enter your email to read for FREE

Get 1 FREE article

Continue with
or
Unlimited Access

Join the Sun for a PENNY A DAY

$0.01/day for 60 days

Cancel anytime

100% ad free experience

Unlimited article and commenting access

Full annual dues ($120) billed after 60 days

By continuing you agree to our
Privacy Policy and Terms of Service.
Advertisement
The New York Sun

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use